scholarly journals The clinical efficacy of low-dose step-up follicle stimulating hormone administration for treatment of unexplained infertility

1999 ◽  
Vol 14 (2) ◽  
pp. 349-353 ◽  
Author(s):  
K. Sengoku ◽  
K. Tamate ◽  
Y. Takaoka ◽  
M. Horikawa ◽  
K. Goishi ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Low Dose ◽  
Follicle Stimulating Hormone ◽  
Unexplained Infertility ◽  
Hormone Administration ◽  
Dose Step ◽  
Stimulating Hormone

scholarly journals Pilot study of the optimal protocol of low dose step-up follicle stimulating hormone therapy for infertile women

2018 ◽  
Vol 17 (3) ◽  
pp. 315-324 ◽  
Author(s):  
Toshiya Matsuzaki ◽  
Takeshi Iwasa ◽  
Rie Yanagihara ◽  
Mizuki Komasaka ◽  
Kiyohito Yano ◽  
...  
Keyword(s):  
Pilot Study ◽  
Hormone Therapy ◽  
Low Dose ◽  
Follicle Stimulating Hormone ◽  
Infertile Women ◽  
Optimal Protocol ◽  
Dose Step ◽  
Stimulating Hormone

scholarly journals Ovarian Stimulation in Obese and Non-Obese Polycystic Ovary Syndrome Using a Low-Dose Step-Up Regimen with Two Different Starting Doses of Recombinant Follicle-Stimulating Hormone

2008 ◽  
Vol 36 (6) ◽  
pp. 1197-1204 ◽  
Author(s):  
R Yildizhan ◽  
E Adali ◽  
A Kolusari ◽  
M Kurdoglu ◽  
B Yildizhan ◽  
...  
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Low Dose ◽  
Polycystic Ovary ◽  
Follicle Stimulating Hormone ◽  
Obese Group ◽  
Ovary Syndrome ◽  
Infertile Women ◽  
Starting Dose ◽  
Dose Step ◽  
Stimulating Hormone

Sixty-seven infertile women with polycystic ovary syndrome (PCOS) were divided into two groups, obese and non-obese, according to their body mass index. Waist-to-hip ratio, insulin resistance, total testosterone and dehydroepiandrosterone sulphate levels were significantly elevated in obese, compared with non-obese, patients. Both groups were treated with a low-dose step-up protocol of recombinant follicle-stimulating hormone (rFSH) with a starting dose of 50 IU/day and, every third day, a 25-IU increase in the dose until the appropriate dose was achieved for each individual, up to a maximum of 175 IU/day. In the obese group only, repeat therapy commenced in the second ovulatory cycle in women who had not become pregnant, however a starting dose of 75 IU/day was then used, with incremental and maximum dose as before. The results of the starting dose of 75 IU/day rFSH were compared with the results of a 50 IU/day rFSH starting dose in the obese group. A starting dose of 50 IU/day rFSH in a low-dose step-up regimen was found to be effective, safe and well-tolerated for inducing follicular development in non-obese infertile women with PCOS. However, for obese PCOS patients, a starting dose of 75 IU/day rFSH is recommended.

Sign in / Sign up

Export Citation Format

Share Document